Merck & Co has entered into an exclusive global license to develop, manufacture and commercialize LM-299 from China-based ...
Microbion's Phase II trial of pravibismane for diabetic foot ulcer infections showed strong safety and positive efficacy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback